Osteoarthritis
-
Biologics
Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee
FDA Determines ReNu Preliminary Clinical Evidence Indicates Potential to Address Unmet Medical Needs for the Management of Symptoms Associated with…
Read More » -
Biologics
Bioventus Receives Authorization to Proceed Under Investigational New Drug Application for Clinical Trial of Placental Tissue Particulate (PTP-001) for the Treatment of Knee OA
November 18, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a leader in Solutions For Innovative Healing, received authorization to proceed under its investigational…
Read More » -
Recon
Total Joint Replacement and the Impact on Future Falls in Osteoarthritis Patients
ROSEMONT, Ill., Oct. 16, 2020 /PRNewswire/ — Patients who have had a total joint arthroplasty (TJA) demonstrate excellent long-term outcomes with increased…
Read More » -
Recon
The LSU Integrated Musculoskeletal Biobank (LIMB): Going to Extremes for ALL Patients
by Elizabeth Hofheinz, M.P.H., M.Ed. The Department of Orthopaedic Surgery at Louisiana State University (LSU) Health – New Orleans is…
Read More » -
Biologics
Bioventus Reaches Milestone with 2 Million DUROLANE® Treatments Worldwide
September 22, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in Innovations For Active Healing, is celebrating a milestone and recognizing…
Read More » -
Biologics
New Approach to Treating Osteoarthritis Advances
NEW YORK, Aug. 10, 2020 /PRNewswire/ — Injections of a natural “energy” molecule prompted regrowth of almost half of the cartilage lost…
Read More » -
Extremities
CyMedica Orthopedics Completes e-vive Parent Clinical Trial for Management of Knee Osteoarthritis Pain
SCOTTSDALE, Ariz., June 16, 2020 CyMedica Orthopedics®, the leading combined muscle strengthening therapy and digital health innovator, announced today that…
Read More » -
Biologics
Bioventus Selects Bazis NN as Distributor of DUROLANE® in Russia
June 15, 2020 HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has selected Bazis NN as its authorized distributor for DUROLANE,…
Read More » -
Hospitals
Study: Hip Arthroscopy for OA=High Conversion to THR, Worse Outcomes
by Elizabeth Hofheinz, M.P.H., M.Ed. A team of researchers from Hospital for Special Surgery (HSS) studying 2,600 patients has found…
Read More » -
Sports Medicine
Human Growth Hormone May Prevent Loss of Muscle Strength after Anterior Cruciate Ligament Reconstruction
NEW YORK, May 26, 2020 /PRNewswire/ — Human growth hormone (HGH) may prevent the loss of muscle strength after anterior cruciate ligament (ACL)…
Read More » -
Biologics
Bone Therapeutics treats first patients in pivotal JTA-004 phase III knee osteoarthritis study
Gosselies, Belgium, 18 May 2020, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high…
Read More » -
OSN Premium
Patients Waiting Too Long to Undergo Knee Replacement
When to get married? When to quarantine? When to have a total knee replacement? A new study can’t help much…
Read More » -
OSN Premium
Study: High Surgeon Satisfaction Using Patient Decision Aids
by Elizabeth Hofheinz, M.P.H., M.Ed., October 11, 2019 In examining 1,220 pre-visit and 967 post-visit surveys, a team of researchers…
Read More » -
OSN Premium
Constance Chu, M.D. on Blood Tests for “Pre-Osteoarthritis” to Help Prevent OA
by Elizabeth Hofheinz, M.P.H., M.Ed., October 4, 2019 Constance Chu, M.D., professor and vice chair of Research in the Department…
Read More » -
Biologics
Bioventus Launches DUROLANE® SJ (1mL) in Australia and New Zealand; Receives Expanded Indications for DUROLANE (3mL)
August 12, 2019 HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, is launching DUROLANE SJ (1mL), and has received…
Read More »